SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-050895
Filing Date
2018-09-13
Accepted
2018-09-13 17:09:31
Documents
2
Period of Report
2018-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 12557
2 POA DOCUMENT poa.txt EX-24.3_809471 983
  Complete submission text file 0001209191-18-050895.txt   14951
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS TIMES SQ TOWER, 7 TIMES SQ, STE 3502 NEW YORK NY 10036
Business Address
Becker Daniel J. (Reporting) CIK: 0001752139 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38653 | Film No.: 181069433